h-index: 7     i10-index: 5

Document Type : Original Research Article


Kish International Campus, University of Tehran, Iran


Still, one of the most basic and often overlooked questions is about contract risk planning. If the scope, technical implications or requirements of a contract are not clear, everything will be opaque. This risk is for the buyer because it was paid for what was not due and for the seller may lead to payment by the buyer or the buyer's claim for damages or termination of the contract. As discussed earlier, contractual disputes arise when one or both parties feel that their rights have been violated. Managing expectations is essential and requires effective communication. For the seller, this includes understanding what the buyer or customer wants, guiding the buyer to what the seller can provide, and clarifying what can be done in the contract. Sometimes it is to reassure the parties by each other of delivery restrictions and what is not available and whatever is within the scope of a contract or outside of it. Effective and transparent communication about the scope of work, technical specifications and requirements promotes the expectations of both parties and reduces the likelihood of failure of one party's activities that lead to frustration of the other party.

Graphical Abstract

Contractual form of Design, Supply and Drilling 1 (EPD) and Its Comparison in Terms of Contractual and Technical Risks with Other Common Contracts in Drilling Exploratory Wells


Main Subjects



©2024 The author(s). This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit: http://creativecommons.org/licenses/by/4.0/


Sami Publishing Company remains neutral concerning jurisdictional claims in published maps and institutional affiliations.


Sami Publishing Company

[1]  N. Kayedi, A. Samimi, M. Asgari Bajgirani, A. Bozorgian, South African Journal of Chemical Engineering, 2021, 35, 153-158. [crossref], [Google Scholar], [Publisher]
[2]  A. Bozorgian, Journal of Engineering in Industrial Research, 2021, 2, 90-94. [crossref], [Google Scholar], [Publisher]
[3]  I. Kaputlu, T. Uzbay, Brain Res., 1997, 753, 98-101. [crossref], [Google Scholar], [Publisher]
[4]  K. Kaviarasam, M.M. Arjunan, K.V. Pugalendi, Clinical Chimica Acta, 2005, 362, 49-56. [crossref], [Google Scholar], [Publisher]
[5] A. Bozorgian, Journal of Engineering in Industrial Research, 2020, 1, 1-19. [crossref], [Google Scholar], [Publisher]
[6] M.E. Bidhendi, Z. Asadi, A. Bozorgian, A. Shahhoseini, M.A. Gabris, Environmental Progress & Sustainable Energy, 2020, 39, 13306. [crossref], [Google Scholar], [Publisher]
[7]  H. King, R.E. Aubert, W.H. Herman, Diabetes care, 1998, 21, 1414-1431. [crossref], [Google Scholar], [Publisher]
[8]  P. Knekt, A. Beunanen, R. Jarvinen, R. Seppane, V.M. Helio, A. Aroma, American Journal of Epidemiology, 1994, 139, 1180-1189. [crossref], [Google Scholar], [Publisher]
[9]  Y. Kumarasamy, L. Nahar, M. Byres, A. Delazar, S.D. Sarker, Journal of herbal pharmacotherapy, 2005, 5, 61-72. [crossref], [Google Scholar], [Publisher]
[10]       T. Kuzuya, S. Nakagawa, J. Satoh, S. Kanazawa, Y. Iwamota, M Kobayashi, Diabetes research and clinical practice, 2002, 55, 65-85. [crossref], [Google Scholar], [Publisher]
[11]       J. Lee, D. Sparrow, P.S. Vokonas, L. Landsberg, S.T. Weiss, American Journal of Epidemiology, 1995, 142, 288-294. [crossref], [Google Scholar], [Publisher]
[12]       F. Zare Kazemabadi, A. Heydarinasab, A. Akbarzadeh, M. Ardjmand, Artificial cells, nanomedicine, and biotechnology, 2019, 47, 3222-3230. [crossref], [Google Scholar], [Publisher]
[13]       F. Zare Kazemabadi, A. Heydarinasab, A. Akbarzadehkhiyavi, M. Ardjmand, Chemical Methodologies, 2021, 5, 135-152. [crossref], [Google Scholar], [Publisher]
[14]       S.M.S. Mirnezami, F. Zare Kazemabadi, A. Heydarinasab, Progress in Chemical and Biochemical Research, 2021, 4, 191-206. [crossref], [Google Scholar], [Publisher]
[15]       A. Bozorgian, Z.A. Aboosadi, A. Mohammadi, B. Honarvar, A. Azimi, Prog. Chem. and Biochem. Rese., 2020, 3, 31-38. [crossref], [Google Scholar], [Publisher]
[16]       A. Bozorgian, S. Zarinabadi, A. Samimi, Journal of Chemical Reviews, 2020, 2, 122-129. [crossref], [Google Scholar], [Publisher]